Highly sensitive C-reactive protein (hs-CRP) is a better indicator of cardiovascular risk compared to traditional assays and has been associated with the severity of CAD, plaque vulnerability and future cardio- and cerebrovascular events in patients that have suffered an ACS [15,16,17]. This evidence concerns the gene CRP and coronary artery disorder.